Skip to main content
Everest Medicines Limited logo

Everest Medicines Limited — Investor Relations & Filings

Ticker · 1952 ISIN · KYG3224E1061 LEI · 3003005FQADBCG83AX84 HKEX Manufacturing
Open in API
Filings indexed 316 across all filing types
Latest filing 2026-05-22 Major Shareholding Noti…
Country KY Cayman Islands
Listing HKEX 1952

About Everest Medicines Limited

http://www.everestmedicines.com

Everest Medicines Limited is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing transformative pharmaceutical products and vaccines. The company focuses on licensing-in and advancing therapies to address critical unmet medical needs, primarily targeting patients across Greater China and other Asian Pacific markets. Its commercialized portfolio includes products such as XERAVA (eravacycline), approved for treating complicated intra-abdominal infections (cIAI).

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY SUBSTANTIAL SHAREHOLDER OF THE COMPANY
Major Shareholding Notification Classification · 95% confidence The document is a voluntary announcement by Everest Medicines Ltd. reporting that its substantial shareholder (CBC Group) and certain directors have purchased additional shares. This is a notification of a change in significant share ownership by a substantial shareholder. It is not a company buyback (POS), not a management change (MANG), and not a regular financial report. It best fits the Major Shareholding Notification category.
2026-05-22 English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY DIRECTOR AND SUBSTANTIAL SHAREHOLDER OF THE COMPANY
Director's Dealing Classification · 92% confidence The announcement details an on-market purchase of 660,000 ordinary shares by Mr. Wei Fu, a non-executive Director and substantial shareholder. This constitutes a personal share transaction by a company director, fitting the definition of Director’s Dealing (insider trade).
2026-05-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-07 English
SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO THE ASSET PURCHASE AGREEMENT
M&A Activity Classification · 90% confidence The document is a supplemental announcement providing additional details on a previously disclosed Asset Purchase Agreement and related transactions. It describes the assignment of contracts, conditions precedent, and background of the seller, which is characteristic of an M&A transaction announcement rather than a financial report or earnings release. It is not a mere notice of publication nor a board change, dividend, or regulatory fallback. Therefore, it falls under M&A Activity (Code: TAR).
2026-04-27 English
Reminder letter and Reply Form to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 95% confidence The document is a reminder letter to non-registered shareholders about the company's adoption of electronic dissemination of corporate communications. It explains what constitutes corporate communications, including directors' reports, annual accounts, auditors' reports, interim reports, notices of meetings, listing documents, circulars, and proxy forms. The letter encourages shareholders to provide their email addresses to receive these communications electronically and offers an option to request printed versions via a reply form. There is no actual financial data, financial statements, or detailed report content included. The document is essentially an announcement about the method of distribution of various corporate reports and communications, not the reports themselves. It is also not a certification or legal proceeding update. Given the nature and length of the document, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2026-04-23 English
2025 Environmental, Social and Governance Report
Regulatory Filings
2026-04-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.